| Literature DB >> 31443525 |
Mara Pilmane1, Elga Sidhoma2, Ilze Akota3, Dzintra Kazoka2.
Abstract
Background and objectives: Cleft lip palate takes the second place among all anomalies. The complex appearance of cytokines and proliferation markers has still not been clarified despite their possible crucial role in cleft tissue. Therefore, the aim of work was the detection of appearance of pro- and anti-inflammatory cytokines and proliferation marker Ki67, and their inter-correlations in cleft affected lip (CAL). Materials andEntities:
Keywords: children; cleft; cytokines; lip; proliferation marker
Mesh:
Substances:
Year: 2019 PMID: 31443525 PMCID: PMC6780708 DOI: 10.3390/medicina55090518
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1(a–d) Micrographs of cleft lip affected lip in children. (a) Note patchy vacuolization of the lip epithelium (keratosis seborrhoea) in a 3-month-old child. Hematoxylin and eosin, X 200; (b) Visible proliferation of the basal epitheliocytes and subepithelial inflammation in a 3-month-old child. Hematoxylin and eosin, X 250. (c) MIP-1ß immunoreactive macrophages are located strictly beneath the basal membrane of 5-month-old child. MIP-1ß IMH, X 200; (d) Note diffuse distribution of MIP-1ß immunoreactive macrophages in subepithelial connective tissue of 4-month-old child. MIP-1ß IMH, X 200.
Relative number of cytokines and proliferation marker Ki67 positive structures in the cleft affected lip epithelium and subepithelial connective tissue.
| Factors/Subjects | Ki67 | IL-1 | IL-4 | IL-6 | IL-8 | IL-10 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | CT | E | CT | E | CT | E | CT | E | CT | |
| 1. | ++/+++ | +/++ | + | +++ | ++ | +++ | ++ | ++/+++ | +++ | +++ | +++ |
| 2. | 0/+ | +++ | ++ | +++ | ++ | ++++ | ++ | +++ | +++ | +++ | +++ |
| 3. | 0/+ | + | ++ | ++ | ++ | +/++ | 0 | 0 | 0 | +/++ | + |
| 4. | 0 | 0 | +/++ | + | + | 0 | ++ | ++ | +/++ | + | + |
| 5. | ++/+++ | ++ | +++ | + | +++ | ++ | +++ | 0 | ++ | ++ | +++ |
| 6. | ++ | +++ | ++ | ++ | +++ | +++ | +++ | ++ | ++ | +++ | ++ |
| 7. | ++ | +++ | ++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | ++ |
| 8. | ++/+++ | +++ | ++ | +++ | +++ | +++ | +++ | +/++ | ++ | +++ | ++ |
| 9. | +++ | +++ | ++ | +++ | +++ | +++ | +++ | 0 | ++ | +++ | ++ |
| 10. | ++/+++ | ++++ | ++ | +++ | +++ | +++ | +++ | 0 | + | ++++ | +++ |
| 11. | 0/+ | +/++ | ++ | + | + | +/++ | ++ | 0/+ | ++/+++ | ++ | ++ |
| 12. | ++ | +++ | ++ | +++ | + | +++ | +++ | ++ | ++ | +++ | ++ |
| 13. | 0/+ | ++ | ++ | 0 | + | +/++ | ++ | 0 | + | ++ | ++ |
| 14. | ++ | +++ | +++ | +++ | +++ | ++/+++ | +++ | 0/+ | +++ | ++/++ | +++ |
| 15. | ++ | ++ | ++ | ++ | ++ | ++ | ++ | +/++ | +++ | ++ | ++ |
| 16. | +/++ | +++ | ++ | +++ | ++ | ++ | +++ | +/++ | +++ | ++ | +/++ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviations: E—epithelium; CT—connective tissue; Ki67—proliferation marker; IL-1—interleukin 1; IL-4—interleukin 4; IL-6—interleukin 6; IL-8—interleukin 8; IL-10—interleukin 10; 0/+—occasional positive structures, +—few positive structures, +/++—few to moderate number of positive structures, ++—moderate number of positive structures, ++/+++—moderate to numerous positive structures, +++—numerous positive cells, +++/++++—numerous to abundant structures, ++++—abundance of positive structures in the visual field; Var—variable appearance of positive structures; * statistically significant difference of the relative number in structures between the subjects and controls.
Figure 2(a–f) Immunohistochemical micrographs in cleft affected lip of children and in control subjects. (a) Note moderate number of basal and suprabasal Ki67 positive cells in epithelium of a 5-month-old cleft affected child. Ki67 IMH, X 200; (b) The lip epithelium lacks Ki67 positive cells in control lip of a 5-year-old child. Ki67 IMH, X 200; (c) Note numerous number of IL-1-containing epithelial and connective tissue cells of 3-month-old cleft affected child. IL-1 IMH, X 200; (d) Moderate number of IL-1 positive connective tissue cells placed in the subepithelium of 6-year-old control child. IL-1 IMH, X 200; (e) Moderate number of IL-4 immunoreactive epitheliocytes and connective tissue cells in subepithelium of 4-month-old cleft affected child. IL-4 IMH, X200. (f) Note moderate number of IL-4 epithelial cells and only few weakly stained connective tissue cells of 6-year- old control subject. IL-4 IMH, X 200.
Figure 3(a–f) Immunohistochemical micrographs of cleft affected lip in children and in control subjects. (a) Note moderate number of IL-6 immunoreactive cells in connective tissue of 1-year-1-month-old cleft affected child. IL-6 IMH, X 200; (b) Moderate number of IL-6 positive connective tissue cells in 6-year-old control lip. IL-6 IMH, X 200; (c) Note moderate number of IL-8 immunoreactive cells located in the epithelium and connective tissue of 4-month-old cleft affected child. IL-8 IMH, X 250; (d) Note moderate number of positive for IL-8 connective tissue cells in 5-year-old control subject. IL-8 IMH, X 200; (e) Note moderate number of IL-10 immunoreactive epitheliocytes and connective tissue cells in 3-month-old cleft affected child. IL-10 IMH, X200; (f) Five-year-old control subject displaying only a few IL-10 positive connective tissue cells. IL-10 IMH, X 200.
Mann–Whitney U test revealing statistically significant differences in factors of different locations between the patients and controls.
| Detected Factor | Mann–Whitney U | Z-Score | |
|---|---|---|---|
| IL-1 in epithelium | 14.5 | 2.06431 | 0.01394 |
| IL-8 in epithelium | 15.5 | 2.35907 | 0.01828 |
| IL-10 in epithelium | 20.5 | 2.33854 | 0.01928 |
| Ki67 in epithelium | 10.5 | 3.00669 | 0.00262 |
| IL-4 in connective tissue | 16 | 2.32221 | 0.02034 |
| IL-10 in connective tissue | 6 | 3.30736 | 0.00094 |
Abbreviations: Ki67—proliferation marker; IL-1—interleukin 1; IL-4—interleukin 4; IL-8—interleukin 8; IL-10—interleukin 10.
Spearman’s rank correlation coefficient revealed correlations between the relative numbers of different tissue factors in CLP affected epithelium and connective tissue.
| Factor 1 | Factor 2 | R | |
|---|---|---|---|
| Very strong positive correlation | |||
| IL-10 in epithelium | IL-8 in epithelium | 0.92791 | 0 |
| Strong positive correlation | |||
| IL-10 in epithelium | IL-4 in epithelium | 0.77857 | 0.00038 |
| IL-10 in epithelium | IL-1 in epithelium | 0.72389 | 0.00152 |
| IL-1 in epithelium | IL-8 in epithelium | 0.77684 | 0.0004 |
| IL-1 in epithelium | IL-4 in epithelium | 0.68943 | 0.00313 |
| IL-4 in epithelium | IL-8 in epithelium | 0.72045 | 0.00164 |
| Ki67 in epithelium | IL-8 in epithelium | 0.64175 | 0.00736 |
| IL-10 in connective tissue | IL-4 in connective tissue | 0.65084 | 0.00632 |
| Moderate positive correlation | |||
| Ki67 in epithelium | IL-10 in epithelium | 0.56539 | 0.02246 |
| IL-1 in connective tissue | IL-4 in connective tissue | 0.55068 | 0.02707 |
| IL-10 in connective tissue | IL-1 in connective tissue | 0.51299 | 0.04214 |
Abbreviations: Ki67—proliferation marker; IL-1—interleukin 1; IL-4—interleukin 4; IL-10—interleukin 10.